Skip to content

SION SION Enterprise value

Enterprise value at other companies

Vertex Pharmaceuticals logo
Vertex PharmaceuticalsVRTX
$109.92B-9.5%
AbbVie logo
AbbVieABBV
$460.96B+24.7%
Septerna, Inc. logo
Septerna, Inc.SEPN
$1.03B+1,325%
BioCryst Pharmaceuticals logo
BioCryst PharmaceuticalsBCRX
$2.63B+46.7%
Denali Therapeutics Inc. logo
Denali Therapeutics Inc.DNLI
$2.69B+37.1%
Neurocrine Biosciences logo
Neurocrine BiosciencesNBIX
$13.41B+18.5%

Other financials

Income statement

See full
Operating income-$29.6M-50.6%
Net income-$26.8M-62.5%
EPS (diluted)-$0.60+3.2%

Balance sheet

See full
Cash & equivalents$64.3M-23.2%
Total debt$8.4M-11.8%
Total equity$288.2M-18.1%
Total assets$305.0M-17.5%

Cash flow

See full
Operating cash flow-$21.8M-34.1%
CapEx--100%
Free cash flow-$21.8M-33.4%

Valuation

See full
Market cap$1.8B

Returns & leverage

See full
Return on equity-26.7%
Debt / equity0.0×
Current ratio22.6×-6.1×

Where this comes from

Calculated from SION’s reported figures.

The official record: SION’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about SION's enterprise value.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is SION's enterprise value?
SION (SION) reported enterprise value of $1.75B in Q1 2026.
What does enterprise value mean?
Market capitalization plus total debt minus cash, at the quarter end. The cost to acquire the whole business — what an buyer pays for equity and debt, net of the cash they'd inherit.